Metzger Michael A
CIK 0001507220 Name as filed on the most recent filing
Filed as Metzger Michael A (26)
48 transaction lines · from 26 filings · filed 2012-02-06 to 2026-07-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Syndax Pharmaceuticals Inc 22 filings
- ISSUER CTI Biopharma Corp 3 filings
- ISSUER Response Genetics Inc 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
48 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 32,375 disposed | 24.24 | 784,776.48 | Form 4, filing 0001193125-26-299803 | |
| 2026-06-01 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 6,847 disposed | 18.99 | 130,024.53 | Form 4, filing 0001193125-26-253601 | |
| 2026-02-09 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 17,159 disposed | 21.03 | 360,819.45 | Form 4, filing 0001193125-26-043814 | |
| 2026-02-06 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 7,412 disposed | 20.62 | 152,835.44 | Form 4, filing 0001193125-26-041500 | |
| 2025-09-08 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 157,307 disposed | 16.41 | 2,582,021.37 | Form 4, filing 0000950170-25-113659 | |
| 2025-07-16 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 7,534 disposed | 9.28 | 69,953.19 | Form 4, filing 0000950170-25-096947 | |
| 2025-03-04 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 7,814 disposed | 15.05 | 117,563.97 | Form 4, filing 0000950170-25-034634 | |
| 2025-02-10 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 13,288 disposed | 15.50 | 206,017.15 | Form 4, filing 0000950170-25-019000 | |
| 2023-02-06 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 5,959 disposed | 27.64 | 164,697.23 | Form 4, filing 0001562180-23-001118 | |
| 2022-11-08 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 50,058 disposed | 5.53 | 276,780.69 | Form 4, filing 0000891293-22-000055 | |
| 2022-11-08 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 36,942 disposed | 5.65 | 208,578.23 | Form 4, filing 0000891293-22-000055 | |
| 2022-11-08 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 4,500 disposed | 5.70 | 25,659.90 | Form 4, filing 0000891293-22-000055 | |
| 2022-10-06 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 16,231 disposed | 25.29 | 410,507.96 | Form 4, filing 0001562180-22-007124 | |
| 2022-10-04 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 1,280 disposed | 25.02 | 32,026.37 | Form 4, filing 0001562180-22-007012 | |
| 2022-10-03 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 2,883 disposed | 25.01 | 72,106.71 | Form 4, filing 0001562180-22-007012 | |
| 2022-09-30 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 29,606 disposed | 25.02 | 740,756.92 | Form 4, filing 0001562180-22-007012 | |
| 2022-07-25 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 19,764 disposed | 21.06 | 416,138.93 | Form 4, filing 0001562180-22-005761 | |
| 2022-07-25 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 11,838 disposed | 21.06 | 249,253.83 | Form 4, filing 0001562180-22-005761 | |
| 2022-07-07 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 100 disposed | 21.00 | 2,100.00 | Form 4, filing 0001562180-22-005637 | |
| 2022-07-07 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 9,000 disposed | 6.50 | 58,500.00 | Form 4, filing 0000891293-22-000036 | |
| 2022-07-07 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 5,900 disposed | 6.51 | 38,409.00 | Form 4, filing 0000891293-22-000036 | |
| 2022-07-07 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 3,321 disposed | 6.52 | 21,652.92 | Form 4, filing 0000891293-22-000036 | |
| 2022-07-07 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 1,100 disposed | 6.55 | 7,205.00 | Form 4, filing 0000891293-22-000036 | |
| 2022-07-07 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 400 disposed | 6.54 | 2,616.00 | Form 4, filing 0000891293-22-000036 | |
| 2022-07-07 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 400 disposed | 6.53 | 2,612.00 | Form 4, filing 0000891293-22-000036 | |
| 2022-07-06 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 15,009 disposed | 21.07 | 316,307.17 | Form 4, filing 0001562180-22-005637 | |
| 2022-07-05 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 51,963 disposed | 6.05 | 314,438.51 | Form 4, filing 0000891293-22-000035 | |
| 2022-07-05 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 27,506 disposed | 6.14 | 168,895.09 | Form 4, filing 0000891293-22-000035 | |
| 2022-07-05 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 8,700 disposed | 5.98 | 51,996.42 | Form 4, filing 0000891293-22-000035 | |
| 2022-07-05 |
CTI Biopharma Corp CTIC |
S, Open-market sale | 3,331 disposed | 6.23 | 20,737.14 | Form 4, filing 0000891293-22-000035 | |
| 2021-12-20 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 45,000 disposed | 20.29 | 912,960.00 | Form 4, filing 0001562180-21-007809 | |
| 2021-12-20 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 16,000 disposed | 20.29 | 324,608.00 | Form 4, filing 0001562180-21-007809 | |
| 2021-12-17 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 1,676 disposed | 19.02 | 31,877.18 | Form 4, filing 0001562180-21-007809 | |
| 2021-12-16 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 22,715 disposed | 19.08 | 433,399.93 | Form 4, filing 0001562180-21-007809 | |
| 2021-12-13 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 34,564 disposed | 19.05 | 658,554.80 | Form 4, filing 0001562180-21-007710 | |
| 2021-12-13 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 2,045 disposed | 19.05 | 38,963.79 | Form 4, filing 0001562180-21-007710 | |
| 2021-10-26 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 16,296 disposed | 19.20 | 312,824.53 | Form 4, filing 0001562180-21-006652 | |
| 2021-10-25 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 44,704 disposed | 19.13 | 855,335.04 | Form 4, filing 0001562180-21-006652 | |
| 2021-09-27 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 24,437 disposed | 19.51 | 476,831.85 | Form 4, filing 0001562180-21-006136 | |
| 2021-09-22 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 300 disposed | 19.02 | 5,706.00 | Form 4, filing 0001562180-21-006060 | |
| 2021-09-21 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 4,808 disposed | 19.16 | 92,108.30 | Form 4, filing 0001562180-21-006060 | |
| 2021-09-20 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 31,455 disposed | 19.24 | 605,046.36 | Form 4, filing 0001562180-21-006060 | |
| 2021-09-14 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 44,349 disposed | 19.15 | 849,394.22 | Form 4, filing 0001562180-21-005948 | |
| 2021-09-13 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 16,651 disposed | 19.02 | 316,638.75 | Form 4, filing 0001562180-21-005948 | |
| 2021-02-01 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 15,000 disposed | 20.19 | 302,799.00 | Form 4, filing 0001562180-21-000869 | |
| 2020-12-01 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 15,000 disposed | 22.97 | 344,512.50 | Form 4, filing 0001562180-20-007070 | |
| 2020-11-04 |
Syndax Pharmaceuticals Inc SNDX |
S, Open-market sale | 100,000 disposed | 20.31 | 2,031,410.00 | Form 4, filing 0001562180-20-006583 | |
| 2012-02-02 |
Response Genetics Inc RGDX |
P, Open-market purchase | 1,000 acquired | 1.50 | 1,500.00 | Form 4, filing 0001144204-12-006166 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 47
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Metzger Michael A, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001507220
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6